Skip to content
10-Q/A

Quarterly Report

Oncolix, Inc.

0001477932-17-005804

← back to feed
Filed
Nov 24, 2017 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Nov 22, 2017 103.88M sh
Operating Cash Flow Q3 2017 · Sep 30, 2017 −$1.55M
Operating Cash Flow restated Q3 2017 · Sep 30, 2016 −$342.9K
Cash And Equivalents Q3 2017 · Sep 30, 2017 $1.36M
Cash And Equivalents Q3 2017 · Dec 31, 2016 $15.26K
Cash And Equivalents Q3 2017 · Sep 30, 2016 $72.27K
Cash And Equivalents Q3 2017 · Dec 31, 2015 $274.06K
Stockholders Equity Q3 2017 · Sep 30, 2017 −$456.93K
Stockholders Equity Q3 2017 · Dec 31, 2016 −$2.13M
Current Liabilities Q3 2017 · Sep 30, 2017 $866.39K
Current Liabilities Q3 2017 · Dec 31, 2016 $1.28M
Total Liabilities Q3 2017 · Sep 30, 2017 $2.13M
Total Liabilities Q3 2017 · Dec 31, 2016 $2.55M
Current Assets Q3 2017 · Sep 30, 2017 $1.68M
Current Assets Q3 2017 · Dec 31, 2016 $382.16K
Total Assets Q3 2017 · Sep 30, 2017 $1.68M
Total Assets Q3 2017 · Dec 31, 2016 $420.84K
Sga Expense Q3 2017 · Sep 30, 2017 $350.3K
Sga Expense Q3 2017 · Sep 30, 2017 $1.14M
Sga Expense Q3 2017 · Sep 30, 2016 $167.89K
Sga Expense restated Q3 2017 · Sep 30, 2016 $440.45K
Rd Expense Q3 2017 · Sep 30, 2017 $76.01K
Rd Expense Q3 2017 · Sep 30, 2017 $153.11K
Rd Expense Q3 2017 · Sep 30, 2016 $77.67K
Rd Expense Q3 2017 · Sep 30, 2016 $656.87K
Net Income Q3 2017 · Sep 30, 2017 −$803.19K
Net Income Q3 2017 · Sep 30, 2017 −$2.14M
Net Income restated Q3 2017 · Sep 30, 2016 −$252.39K
Net Income restated Q3 2017 · Sep 30, 2016 −$1.1M